Piranha Pond is produced by the 128 Innovation Capital Group
Copyright 2011, Business Professionals
You've heard of the Shark Tank..... Welcome to the Piranha Pond!
At the Piranha Pond, Entrepreneurs seeking funding have a 5-minute opportunity to convince a panel of Investors to give them the money.

The next Piranha Pond Pitch Party is scheduled for Thursday, February 16, 2012 at

What is the Piranha Pond? It is a "pitch party" where a select group of entrepreneurs has up to 5 minutes to convince a panel of investors to meet with them to discuss funding their ventures. Using a format similar to the popular television show Shark Tank, our investors provide feedback to the entrepreneurs about their presentations and companies, and information to all about why they decide to be "In" or "Out." If they are "In" they will meet with the Entrepreneur at a later time to discuss their company. If they are "Out" there is no interest at this time. Again, the investor lets us know why they will not move forward with the presenter.

Thursday, February 16, 2012 - 7:30 am to 10:30 am

Enterprise Center at Salem State University, 121 Loring Ave., Salem, MA

Click Here to Register to Pay with a Credit Card

Please Click Here to Register and Pay at the Door

Application Period is from 1/11/2012 - 2/8/2012

Applications are no longer being accepted for this event.

Investor Panel

Rick Blume

Excel Venture Management

http://www.excelvm.com/investment.html

Rick Blume has been financing companies in healthcare for over three decades. His early investment banking career involved financing and banking relationships with hospitals, payers, physicians, and new biotech companies. The excitement he saw at Genentech, in its early years, led him to transition into venture capital in the mid 1980's.  Rick co-founded CB Health Ventures in 1998 where he assembled what is now the core of Excel.

The firm's investments include diagnostics, medical devices, healthcare services and medical informatics. They are increasingly focused on life science technologies that are also applicable to industries outside healthcare, including agriculture, environment, energy and defense. They do not invest in single molecule drugs.

  • Type of Investment  - Healthcare and Life Science
  • Stage of Investment  - Early to late stage
  • Focus Healthcare Sectors  - Diagnostics, Devices, Healthcare IT and Services, Life Science Platforms
  • Other Related Life Science Industries  - Agriculture, Energy, Materials, IT, Defense
  • Initial Investment - $1-5M

Jeff Potter

Esker Capital

Jeff is an Angel Investor who spent many years with Capital Resource Partners. As an individual angel investor though, many of his criteria remain the same: a deep management team running a company whose offering has a good, recurring revenue model. He looks favorably at service oriented businesses who are profitable, and who will be able to scale the business with additional investment.


    Robert Jevon

    Boston Millennia Partners

    http://www.bostonmillenniapartners.com/Default.asp

    Mr. Jevon has been a Partner at Boston Millennia Partners since its founding in 1997. He was previously a venture partner at Boston Capital Ventures, which he joined in 1996. Prior to that, he was Managing Director and co-owner of Watch Hill Corporation, a Boston based private investment firm. Previously, he was Controller of Bolt, Beranek and Newman’s Communications Division. He also gained significant operational and international experience stationed in Copenhagen as Finance Director of BBN Communications A/S. His earlier business career included several assignments in General Electric’s Financial Management Program.

    We seek to partner with highly capable entrepreneurs whose talents and experience will translate into successful ventures. Potential portfolio companies should meet the following general investment criteria:

    • Experienced management team with a record of demonstrable success
    • Product or service offering with a sustainable competitive advantage
    • An addressable market exceeding $500 million and growing rapidly

    In order to take full advantage of our expertise in the healthcare and life sciences sector, we use a multi-stage investment approach, investing in growth stage and late stage companies. We seek companies that have existing customers, or a product or service for which there is a high degree of confidence as to the addressable market. We seek companies that have existing customers and are at or near breakeven.


    Bill McCullen

    Launch Capital Ventures

    www.launch-capital.com

    Bill is an experienced private investor, with over 7 years backing companies in the networking, semiconductor, clean energy and online markets.  Bill has been in/around the Boston startup scene for close to 15 years, previously holding senior level roles at companies such as Sycamore Networks. Bill received his BS and MS degrees in Electrical Engineering at Worcester Polytechnic Institute and an MBA from the MIT Sloan School of Management.  Bill is a lifelong Bostonian who currently lives in the suburbs with his wife and 3 children. When he has time he enjoys playing basketball and cycling.

    LaunchCapital Ventures provides seed funding for businesses that have exponential growth expectations with a national or international reach. We syndicate over 90% of our deals with local angel investors and venture capitalists.  We will take on an active role with our portfolio companies depending on the needs and nature of the business.


    Richard Noyes

    Beacon Angels

    http://www.beaconangels.com

    Mr. Noyes is a retired financial executive whose career has included CFO positions with a UK-owned US R&D and defense products firm, QinetiQ NA (formerly Foster Miller, Inc) and the pharmaceutical giant AstraZeneca. Richard started his career in engineering with GE after receiving degrees from Dartmouth College. He later switched to accounting and finance starting with Ernst & Young after receiving an MBA from Amos Tuck and a later MSF from Bentley University. Richard is a CPA/CMA with a Top Secret Security Clearance. He is currently serving on the board of a small So. Maine building products company. Mr. Noyes has extensive experience in business valuations and has worked on several acquisitions from both the buy and sell side.

    Investment Criteria for Beacon Angels:

    • Foreseeable exit strategy.
    • Competitive barriers to entry.
    • Significant third party buy-in (from customers and/or investors).
    • $3 million or less pre-money valuation.
    • Concise, compelling plan, organized documentation.
    • New England companies preferred.

    In 2012 we will be in Waltham again on June 14, 2012.

    You can see what happened on June 9, 2011 by clicking here.

    You can see what happened on Novembe 10, 2011 by clicking here.